These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8372811)

  • 1. DDAVP in acquired hemophilia A: case report and review of the literature.
    Mudad R; Kane WH
    Am J Hematol; 1993 Aug; 43(4):295-9. PubMed ID: 8372811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of patients with hemophilia A and von Willebrand disease to desmopressin (DDAVP).
    Santiago-Borrero PJ; Casanova R
    Bol Asoc Med P R; 1990 May; 82(5):207-10. PubMed ID: 2115785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical efficacy of desmopressin in the treatment of mild hemophilia A in children].
    Bai ST; Lu J; Sheng GY; Xu ST; Xie L; Peng S
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Sep; 13(9):715-7. PubMed ID: 21924018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-Deamino-8-D-arginine vasopressin in the treatment of non-haemophilic patients with acquired factor VIII inhibitor.
    Muhm M; Grois N; Kier P; Stümpflen A; Kyrle P; Pabinger I; Bettelheim P; Hinterberger W; Lechner K
    Haemostasis; 1990; 20(1):15-20. PubMed ID: 2108912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmopressin therapy in patients with acquired factor VIII inhibitors.
    Naorose-Abidi SM; Bond LR; Chitolie A; Bevan DH
    Lancet; 1988 Feb; 1(8581):366. PubMed ID: 2893182
    [No Abstract]   [Full Text] [Related]  

  • 6. DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease.
    Warrier AI; Lusher JM
    J Pediatr; 1983 Feb; 102(2):228-33. PubMed ID: 6401806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal DDAVP: biological and clinical evaluation in mild factor VIII deficiency.
    Chistolini A; Dragoni F; Ferrari A; La Verde G; Arcieri R; Ege Mohamud A; Mazzucconi MG
    Haemostasis; 1991; 21(5):273-7. PubMed ID: 1806455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of 1-deamino 8 D-arginine vasopressin (DDAVP) in a nonhaemophilic patient with an acquired type II factor VIII inhibitor.
    de la Fuente B; Panek S; Hoyer LW
    Br J Haematol; 1985 Jan; 59(1):127-31. PubMed ID: 3918556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DDAVP and its effect on factor VIII activity (author's transl)].
    Sikorová J; Vorlová Z
    Cas Lek Cesk; 1981 May; 120(18):553-6. PubMed ID: 6794913
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical significance of different routes of desmopressin (DDAVP) administration in various bleeding disorders.
    Mörsdorf S; Köhler M; Leipnitz G; Wenzel E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):503-7. PubMed ID: 2465962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDAVP (desmopressin) in the dental management of patients with mild or moderate hemophilia and von Willebrand's disease.
    Vierrou AM; de la Fuente B; Poole AE; Hoyer LW
    Pediatr Dent; 1985 Dec; 7(4):297-301. PubMed ID: 2938080
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of 1-deamino-8-D-arginine vasopressin (DDAVP) on blood coagulation in patients with hemophilia A and in healthy men].
    Blättler W; Jacky E; Müller M; Graf M
    Schweiz Med Wochenschr; 1979 Sep; 109(37):1367-8. PubMed ID: 314661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desmopressin in moderate hemophilia A patients: a treatment worth considering.
    Loomans JI; Kruip MJHA; Carcao M; Jackson S; van Velzen AS; Peters M; Santagostino E; Platokouki H; Beckers E; Voorberg J; van der Bom JG; Fijnvandraat K;
    Haematologica; 2018 Mar; 103(3):550-557. PubMed ID: 29305412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New ways to boost factor VIII in hemophilia: DDAVP for mild hemophilia A, von Willebrand's.
    Marwick C
    JAMA; 1983 Jun; 249(24):3278-9. PubMed ID: 6406692
    [No Abstract]   [Full Text] [Related]  

  • 17. [Progress in the treatment of mild hemophilia. Liberation of factor VIII from the vascular endothelium with 1-desamino-8-D-arginine vasopressin].
    Tjønnfjord GE; Evensen SA; Stormorken H; Trebo S
    Tidsskr Nor Laegeforen; 1989 Apr; 109(12):1291-2. PubMed ID: 2499950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy and determinants of response to treatment with desmopressin in mild hemophilia a.
    Di Perna C; Riccardi F; Franchini M; Rivolta GF; Pattacini C; Tagliaferri A
    Semin Thromb Hemost; 2013 Oct; 39(7):732-9. PubMed ID: 24030345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors to factor VIII in a family with mild hemophilia: molecular characterization and response to factor VIII and desmopressin.
    Santagostino E; Gringeri A; Tagliavacca L; Mannucci PM
    Thromb Haemost; 1995 Aug; 74(2):619-21. PubMed ID: 8584995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DDAVP challenge tests in boys with mild/moderate haemophilia A.
    Revel-Vilk S; Blanchette VS; Sparling C; Stain AM; Carcao MD
    Br J Haematol; 2002 Jun; 117(4):947-51. PubMed ID: 12060135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.